MINDCURE adds a new tech specialist to direct the development of its iSTRYM R&D platform.
Ionic Brands (CSE: IONC) is creating a multi-state, consumer focused, premium cannabis porfolio consisting of iconic national brands.
They have:
- Stylish products
- World Class Management Team
- A proven and repeatable strategy for success
Experienced and proven luxury cannabis concentrates brand
One of the tops selling vape brands in WA State with a loyal customer base
Largest standalone oil manufacturer in the state of WA
Consistent sales growth over 3 years with a verified marketing blueprint
Offers investors exposure to a premium luxury cannabis brand
Demonstrated to have a winning formula to become the top vape company in WA
Massive growth opportunity available with expansion into OR, NV and CA
MINDCURE adds a new tech specialist to direct the development of its iSTRYM R&D platform.
Psychedelic drug stocks represent (by far) the best new opportunity in life sciences today. Institutional capital is flooding into the sector. But market analysts are asleep-at-the-wheel here.
A chain of cannabis dispensaries in Arizona is offering an enticing incentive to those who have received a Covid-19 vaccine: free marijuana edibles.
The use of psychedelic substances is associated with better physical health, according to preliminary research published in the Journal of Psychopharmacology.
Scientists have used advanced computer simulations to better understand the neurobiological mechanisms underlying the psychedelic experience.
California officials have awarded $15 million in grant funding through the Governor’s Office of Business and Economic Development (GO-Biz) and Bureau of Cannabis Control’s Cannabis Equity Grants program.